GH Guardant Health, Inc. | US40131M1099
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 1.715.362.060 | 1.314.412.130 | 30.50% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -0,43 | -1,39 | 68.94% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 18 | 19 | 5.26% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |